Page 5 - Lexaria Bioscience News Today

NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. LEXX announces the availability of a broadcast titled, "Exciting New…

NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. LEXX today announces its placement in an editorial published by ("NNW"), one of 60+…

Lexaria Bioscience Corp. (NASDAQ:LEXX) shares lost ground Thursday. The global innovator in drug delivery platforms announces positive final results from its recently completed human Pilot Study #1 evaluating DehydraTECHTM technology for the oral delivery ...

Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Insider & Institutional Ownership 31.3% of Edesa […]

Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Edesa Biotech (NASDAQ:EDSA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Volatility & Risk Lexaria Bioscience has a […]

Invenomic Capital Management LP raised its stake in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 62.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 766,573 shares of the company’s stock after buying an additional 293,470 shares during the quarter. Invenomic Capital Management LP owned approximately 9.48% […]

07.12.2023 - KELOWNA, BC / ACCESSWIRE / December 7, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the Company or Lexaria), a global innovator in drug delivery platforms, announces that the Companys anticipated submission of an Investigational ... Seite 1

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...